NPI: 1689126757 · ORLANDO, FL 32822 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 10/25/2016
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 10/25/2016 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 2,780 | $348K |
| 2019 | 15,587 | $1.81M |
| 2020 | 18,371 | $2.19M |
| 2021 | 12,627 | $835K |
| 2022 | 6,742 | $1.62M |
| 2023 | 633 | $101K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 17,768 | 825 | $2.23M |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 16,390 | 1,129 | $2.17M |
| J1270 | Injection, doxercalciferol, 1 mcg | 11,071 | 693 | $1.13M |
| A4657 | Syringe, with or without needle, each | 2,190 | 853 | $432K |
| J1756 | Injection, iron sucrose, 1 mg | 4,440 | 667 | $385K |
| 85041 | 1,006 | 506 | $116K | |
| 83970 | 1,021 | 557 | $115K | |
| 85048 | 948 | 467 | $103K | |
| 83540 | 532 | 287 | $60K | |
| 83550 | 531 | 287 | $59K | |
| 82728 | 511 | 258 | $57K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 184 | 104 | $26K |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 73 | 30 | $11K |
| 82108 | 27 | 17 | $4K | |
| 82607 | 22 | 15 | $2K | |
| 82652 | 26 | 13 | $653.52 |